Shortage of Anti-Snake Venom Worsens; Costs Reach N250,000, According to Gombe Hospital Director

Dr. Nicholas Amani, who serves as the Medical Director of the Snakebite Hospital and Research Centre located in Kaltungo, Gombe State, has brought attention to the critical shortage of anti-snake venom, noting that it is not only rare in Nigeria but also in many other countries around the world.

He made these remarks during an interview with Punch, in relation to the tragic death of aspiring singer Ifunanya Nwangene, who succumbed to a snakebite in her residence in Abuja.

Amani addressed the broader issues surrounding snakebite management both within Nigeria and internationally, stating,

"The truth of the matter is that anti-snake venom is indeed a rare commodity globally. This situation arises since snakebites predominantly affect marginalized groups, including farmers and residents of rural areas — those who lack representation and a strong voice in society.

At every conference and international gathering we attend, scarcity is the recurrent theme. There are no complimentary stocks of anti-snake venom available, as the majority are now out for sale through pharmacy dealers," he explained.

Despite an increase in awareness about the dangers of snakebites as a significant public health threat, Amani pointed out that specialized hospitals still grapple with insufficient anti-snake venom supplies.

He further elaborated,

"I must clarify that even in specialized healthcare facilities, we currently lack anti-snake venom. The government is making efforts to address this issue as it has become a crucial health challenge, but the solutions are still in progress."

Using Kaltungo as a case study, Amani revealed that patients frequently have to acquire this life-saving medication from private vendors.

"In Kaltungo, for instance, it is predominantly local pharmacists and business owners who are supplying the anti-venom. Patients are compelled to purchase it from these individuals, highlighting the genuine issue of scarcity," he added.

When discussing the financial implications of obtaining anti-snake venom, Amani noted,

"At this moment, a single vial of anti-snake venom costs an estimated N250,000. Many patients need two or three vials. Those who come in after snake bites often belong to impoverished backgrounds; they are forced to sell their farms and personal belongings to afford just one vial. Consider the situation when two or three vials are necessary," he expressed mournfully.